AssetMark’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
Other funds holding HRMY
AssetMark's HRMY Position: Q3 2026 in Review
AssetMark increased its Harmony Biosciences (HRMY) stake by 43% in Q3 2026, buying an estimated $1.12K and bringing the position to 97 shares worth $3.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2840.
AssetMark first reported a position in HRMY in Q4 2023 and has held it in 12 quarters since. 279 funds tracked by Wall St. Rank hold HRMY as of Q3 2026.
- AssetMark held 97 shares of Harmony Biosciences worth $3.81K as of Q3 2026.
- AssetMark bought 29 Harmony Biosciences shares in Q3 2026, an estimated $1.12K.
- Harmony Biosciences made up ﹤0.01% of AssetMark's portfolio in Q3 2026, its #2840 holding.
- AssetMark first reported a position in Harmony Biosciences in Q4 2023 and has held it in 12 quarters since.
- 279 funds tracked by Wall St. Rank held Harmony Biosciences as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.